by cristiano | Oct 17, 2018
HLA-DQ2/DQ8 genotyping is appropriate only in cases of uncertain diagnosis and in subjects with increased risk, like family members of celiac patients (to exclude from subsequent repeated controls the subjects who are negative) and patients with a disease implying an...
by cristiano | Oct 17, 2018
According to national and international recommendations and guidelines, testing should not be performed outside of specific medical conditions, e.g.: episodes of venous thrombosis at an early age or the presence of strong familial history, with two or more affected...
by cristiano | Oct 17, 2018
Only in the case where the geneticist recognizes a reproductive risk for a specific monogenic disease, the genetic test for that single disease should be performed on the component at risk. Whether a monogenic autosomal recessive disease is present, the test should be...
by cristiano | Oct 17, 2018
The public may be misled about the real benefit of these tests and it is often not aware of the limitations of the test. Without consulting a geneticist is also difficult to interpret correctly the test result. Finally, it is found that those who undergo the tests...
by cristiano | Oct 17, 2018
Since the risk of developing thrombotic events is conferred by the presence of hyperhomocysteinemia, it is considered more useful and valid, from the clinically point of view, consider the value of plasma homocysteine, which is also influenced by several other...
Recent Comments